Drug factory · FDA FEI 3008426496

Adhexpharma

42-44 rue de Longvic, Chenove, France

France: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 14, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2019: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
RivastigmineMakes it Breckenridge Pharmaceutical, Inc. 51991-897, 51991-898, 51991-899

FDA inspection history

EndedResultProgramProblems noted
Jun 14, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 19, 2019Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: manufacture.